Lidocaïnehydrochloride 10 Mg/Ml, Injectievloeistof

Lidocaine Hydrochloride, the active ingredient in Lidocaïnehydrochloride 10 Mg/Ml, Injectievloeistof, is a local anesthetic presented as a 10 mg/mL injectable solution for intravenous use. It provides reversible nerve impulse blockade for local anesthesia during minor surgical procedures, nerve block techniques, and management of ventricular arrhythmias.

GNH USA supplies Lidocaïnehydrochloride 10 Mg/Ml, Injectievloeistof as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Lidocaine Hydrochloride is used in the management of pain and cardiac rhythm disorders through sodium‑channel blockade. - Minor surgical procedures: provides rapid local anesthesia to enable pain‑free operations. - Nerve block anesthesia: produces targeted regional numbness for diagnostic or therapeutic interventions. - Ventricular arrhythmias: stabilises cardiac electrical activity during acute arrhythmic episodes.

Lidocaine Hydrochloride may cause a range of adverse reactions, most of which are dose‑related and transient.

Common Side Effects: - Tingling or numbness at the injection site. - Transient dizziness or light‑headedness. - Metallic taste in the mouth. - Mild headache. - Nausea.

Serious or Rare Side Effects: - Severe hypotension or cardiovascular collapse. - Cardiac arrhythmias, including ventricular tachycardia. - Anaphylactic or severe allergic reaction. - Central nervous system toxicity (e.g., seizures, loss of consciousness).

When using Lidocaine Hydrochloride, careful assessment and monitoring are essential to minimise risks. - Assess allergy history: confirm no known hypersensitivity to amide‑type local anesthetics. - Monitor cardiovascular status: observe blood pressure and heart rhythm during administration. - Use incremental dosing: inject slowly to reduce systemic toxicity. - Avoid intravascular injection: aspirate before each dose. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lidocaine Hydrochloride can interact with several drug classes, requiring attention to avoid enhanced toxicity.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may increase systemic toxicity. - Beta‑blockers (e.g., propranolol): can exacerbate cardiac depression. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise plasma lidocaine levels.

Moderate Interactions (Monitor Closely): - Concurrent use with other local anesthetics: additive toxicity risk. - General anesthetics (e.g., propofol): may potentiate central nervous system depression. - Diuretics (e.g., furosemide): may alter plasma protein binding and affect lidocaine concentration.